3D DRUG PRINTING- A SWING FROM LABORATORY PRODUCTION TO COMPUTERIZED PRODUCTION
Three-Dimensional (3D) printing is a process where objects are made in successive layers under computer control by fusing or depositing materials. The objects can be of nearly any shape or geometry and come in a computer-aided (CAD) design from 3D model. Since 3D printing began in 1984, it has changed enormously and has been used in a wide range of fields, including medicine and architecture. 3D printing moves rapidly and in future will transform and change the way we live and work from laboratory-based organs to pharmaceutical supplies.
3D printing in pharmaceuticals has been used to produce many novel dosage forms like microcapsules, complex drug-release profiles, nanosuspensions, and multilayered drug delivery devices. It also offers important advantages from the industrial point of view such as cost-efficiency, higher productivity, democracy-making and enhanced cooperation.
Keeping in view the recent approval given by USFDA to many drug the focus has now shifted to the personalized medicine as it offers an important benefit to patients who need medications that have narrow therapeutic index or a higher predilection to be influenced by genetic polymorphisms. 3D printer is now seen as a valuable, efficient and economical tool to manufacture individualized medications, tailored to specific patients based on their needs and thereby change the future of pharmacy practice in general and pharmaceutical care in particular.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).